$25.37
Today
as of Jul 22, 16:53 ET
Last 30 days
Recent Press Releases & News
PRVA: Lowering target price to $28.00
PRVA: What does Argus have to say about PRVA?
Privia Health Group Insider Sold Shares Worth $588,679, According to a Recent SEC Filing
Overview
52-week range
$19
$27
85% of range
Avg surprise (last 3)
-61.7%
Avg reaction (last 2)
+3.8%
50% positive
Latest IV / EM
50%
EM ±11.3% · $25 · Aug 21
Earnings trends
EPS — actual vs estimate
Actual Estimate
Revenue vs Net Income
Revenue Net income
Earnings history
| Date | Period | Actual EPS | Est | Surprise | YoY %Δ | Day react | Source |
|---|---|---|---|---|---|---|---|
| Thu May 7, 2026 | Mar/2026 | $0.02 | $0.08 | -75.0% | -33.3% | 0.0% | earnings |
| Tue Sep 30, 2025 | Sep 2025 | $0.05 | — | — | — | — | financials |
| Thu Aug 7, 2025 | Jun/2025 | $0.02 | $0.05 | -60.0% | — | — | earnings |
| Thu May 8, 2025 | Mar/2025 | $0.03 | $0.06 | -50.0% | — | +7.5% | earnings |
| Mon Sep 30, 2024 | Sep 2024 | $0.03 | — | — | — | — | financials |
| Sun Jun 30, 2024 | Jun 2024 | $0.03 | — | — | — | — | financials |
| Sun Mar 31, 2024 | Mar 2024 | $0.02 | — | — | — | — | financials |
| Sat Sep 30, 2023 | Sep 2023 | $0.05 | — | — | — | — | financials |
| Fri Jun 30, 2023 | Jun 2023 | $0.06 | — | — | — | — | financials |
Upcoming
| Date | Fiscal | Time | EPS Est | LY EPS | YoY %Δ |
|---|---|---|---|---|---|
| Thu Aug 6, 2026 | Jun/2026 | BMO | $0.08 | $0.02 | +300.0% |
Financials
Income statement (quarterly)
| Metric | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 |
|---|---|---|---|---|---|---|---|---|
| Revenue | $604M | — | $580M | $521M | $480M | — | $438M | $422M |
| Cost of revenue | — | — | — | — | — | — | — | — |
| Gross profit | — | — | — | — | — | — | — | — |
| Operating income | $7M | — | $14M | $3M | $5M | — | $6M | $5M |
| Net income | $3M | — | $7M | $3M | $4M | — | $4M | $3M |
| EPS (diluted) | $0.02 | — | $0.05 | $0.02 | $0.03 | — | $0.03 | $0.03 |
Balance sheet (quarterly)
| Metric | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 |
|---|---|---|---|---|---|---|---|---|
| Cash & equivalents | $420M | $480M | $441M | $390M | $469M | $491M | $422M | $387M |
| Inventory | — | — | — | — | — | — | — | — |
| Total current assets | $966M | $911M | $971M | $883M | $886M | $835M | $854M | $780M |
| Total assets | $1.42B | $1.37B | $1.35B | $1.27B | $1.18B | $1.14B | $1.15B | $1.08B |
| Long-term debt | — | — | — | — | — | — | — | — |
| Total liabilities | $612M | $578M | $588M | $539M | $474M | $452M | $483M | $434M |
| Total equity | $753M | $737M | $709M | $683M | $659M | $635M | $615M | $595M |